By Dean Seal
Shares of Verastem are trading higher after the company’s recent update on its ovarian cancer treatment turned Mizuho analysts bullish on the stock.
The stock is up 13% at $10.53 in early trading. Shares have more than doubled since the start of the year but are still trading lower than they were a year ago.
The…